This article is
- freely available
Viruses 2010, 2(7), 1448-1457; doi:10.3390/v2071448
siRNA for Influenza Therapy
Department of Biochemistry and Molecular Biology, University of South Alabama, College of Medicine, MSB 2370, 307 University Boulevard, Mobile, AL 36688-0002, USA
Received: 1 June 2010; in revised form: 5 July 2010 / Accepted: 7 July 2010 / Published: 9 July 2010
(This article belongs to the Special Issue Antivirals Against Influenza)
Download PDF Full-Text [102 KB, uploaded 9 July 2010 15:36 CEST]
Abstract: Influenza virus is one of the most prevalent and ancient infections in humans. About a fifth of world's population is infected by influenza virus annually, leading to high morbidity and mortality, particularly in infants, the elderly and the immunocompromised. In the US alone, influenza outbreaks lead to roughly 30,000 deaths each year. Current vaccines and anti-influenza drugs are of limited use due to high mutation rate of the virus and side effects. In recent years, RNA interference, triggered by synthetic short interfering RNA (siRNA), has rapidly evolved as a potent antiviral regimen. Properly designed siRNAs have been shown to function as potent inhibitors of influenza virus replication. The siRNAs outperform traditional small molecule antivirals in a number of areas, such as ease of design, modest cost, and fast turnaround. Although specificity and tissue delivery remain major bottlenecks in the clinical applications of RNAi in general, intranasal application of siRNA against respiratory viruses including, but not limited to influenza virus, has experienced significant success and optimism, which is reviewed here.
Keywords: influenza virus; short interfering RNA; RNA interference; antiviral
Article StatisticsClick here to load and display the download statistics.
Notes: Multiple requests from the same IP address are counted as one view.
MDPI and ACS Style
Barik, S. siRNA for Influenza Therapy. Viruses 2010, 2, 1448-1457.AMA Style
Barik S. siRNA for Influenza Therapy. Viruses. 2010; 2(7):1448-1457.Chicago/Turabian Style
Barik, Sailen. 2010. "siRNA for Influenza Therapy." Viruses 2, no. 7: 1448-1457.